News_爱宠生物官网、猫三联、宠物狂犬疫苗、狗狂犬疫苗、猫狂犬疫苗

Company dynamics Honorary award Investor relations

Company dynamics

Company dynamics

Pet rabies vaccine products will be officially put into production

See more

Recently, after the review of the Ministry of Agriculture and Rural Affairs, the Guangxi Base of Aichong Biological Group (Guangxi Aichong Biotechnology Co., LTD.) was approved to produce rabies vaccine products, and issued the approval number of veterinary medicine products (veterinary medicine word 200766048). The approval means that the pet rabies vaccine products of Aichong Biology will be officially put into production, which is an extremely important milestone for the development of Aichong Biology Group.

Honorary award

Honorary award

Appearance design patent certificate

The Most Valuable Investment Brand in the Industry for 2022

Winner of China Innovation and Entrepreneurship Competition

The Most Influential Brand in the Industry in 2021

See more

Investor relations

Investor message

Announcement circular

回到顶部